Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-15.33%Free Cash Flow Yield
VS
Market
Sector
Industry
History
$ 11.25Close
$ 8.84 - $ 12.53 52-Week Range
Ticker Information
Ticker
BBOTCompany Name
BRIDGEBIO ONCOLOGY THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQBRIDGEBIO ONCOLOGY THERAPEUTICS INC - Free Cash Flow Yield Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
BBOT - FCF Yield Historical data
| Date | Free Cash Flow | Free Cash Flow Yield | Market Capitalization |
|---|---|---|---|
| 6/30/2025 | $ -97.71M | -15.33% | $ 637.52M |
| 3/31/2025 | $ -880.46K | -0.35% | $ 255.07M |
| 12/31/2024 | $ -763.82K | -0.3% | $ 251.55M |
| 9/30/2024 | $ -675.96K | -0.27% | $ 247.43M |
| 6/30/2024 | $ 0 | 0% | $ 244.49M |
| 3/31/2024 | $ 0 | 0% | $ 237.82M |
| 12/31/2023 | $ 0 | 0% | $ 0 |
Key Performance Insights, Last 5 Years
- BRIDGEBIO ONCOLOGY THERAPEUTICS INC's latest trailing twelve months (TTM) FCF Yield stands at 0%.
- Over the past 5 years, BRIDGEBIO ONCOLOGY THERAPEUTICS INC's average FCF Yield has been -4.06%.
- The median FCF Yield for BRIDGEBIO ONCOLOGY THERAPEUTICS INC during this period was -0.32%
- BRIDGEBIO ONCOLOGY THERAPEUTICS INC reached its highest FCF Yield over the past 5 years at -0.27%.
- The lowest FCF Yield recorded by BRIDGEBIO ONCOLOGY THERAPEUTICS INC in the same timeframe -15.33%
Similar metrics to Market Cap:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Free Cash Flow - [Calculation] Free Cash Flow is a metric that measures the cash that remains after a company pays its operating expenses [OpEx] and capital expenditures [CapEx]. It can be calculated as Net Cash Flow from Operations [NCFO] minus capital expenditures.
- Earnings Yield - [Calculation] The Earnings Yield, also known as the inverse of the PE ratio [PE], expresses a company’s earnings [NetIncCmn] as a percentage of [MarketCap].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
Definition of Free Cash Flow Yield
[Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.FCF / Market Cap
(=) FCF Yield FCF Yield for BRIDGEBIO ONCOLOGY THERAPEUTICS INC is calculated as follows: FCF [ $ 0 ] / Market Cap [ $ 0 ]
(=) FCF Yield [ 0% ] BBOT - Free Cash Flow Yield, Last 5 years
-15.33%
Minimum
Jun 30, 2025
-0.27%
Maximum
Sep 30, 2024
-4.06%
Average
-0.32%
Median
FCF Yield Benchmark AnalysisMarket
The chart above depicts the distribution of FCF Yield for companies in the Total Stock Market. The average FCF Yield of the companies is 1.58% with a standard deviation of 11.38%.
The following table provides additional summary stats:
FCF Yield in the Market:
| filtered constituents | 3.58K |
|---|---|
| min | -33.87% |
| max | 37.55% |
| average | 1.58% |
| median | 3.22% |
| std | 11.38% |